Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17.

ABSTRACT:

Background and aims

Opioid overdose is a leading cause of death during the immediate time after release from jail or prison. Most jails in the United States do not provide methadone and buprenorphine treatment for opioid use disorder (MOUD), and research in estimating its impact in jail settings is limited. We aimed to test the hypothesis that in-jail MOUD is associated with lower overdose mortality risk post-release.

Design, setting and participants

Retrospective, observational cohort study of 15 797 adults with opioid use disorder who were released from New York City jails to the community in 2011-2017. They experienced 31 382 incarcerations and were followed up to 1 year.

Measurements

The primary outcomes were death caused by accidental drug poisoning and all-cause

SUBMITTER: Lim S 

PROVIDER: S-EPMC9898114 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature